TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Operating margin 2016–2025
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) operating margin by fiscal year — reported operating income divided by reported revenue.
12.5%FY2025 · since FY2016: 9.8% → 12.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 12.5% | +14.3 pp |
| FY2024 | -1.8% | -4.6 pp |
| FY2023 | 2.7% | +17.5 pp |
| FY2022 | -14.7% | -25.5 pp |
| FY2021 | 10.8% | +32.2 pp |
| FY2020 | -21.4% | -18.8 pp |
| FY2019 | -2.6% | +6.3 pp |
| FY2018 | -9.0% | +71.0 pp |
| FY2017 | -80.0% | -89.8 pp |
| FY2016 | 9.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TEVA financial trends
TEVA RevenueTEVA Net incomeTEVA Net marginTEVA Gross profitTEVA Gross marginTEVA Operating incomeTEVA Operating cash flowTEVA Free cash flowTEVA Capital expendituresTEVA Return on equityTEVA Stock buybacksTEVA Dividends paidTEVA Total assetsTEVA Total liabilitiesTEVA Shareholders’ equityTEVA overview →